Clinical Trial Update: A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. [Phase 3]

View source ↗

Summary

This Phase 3 trial compared an aliskiren-based hypertension regimen to a ramipril-based regimen, followed by randomized withdrawal, and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Altace (ramipril)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED